Insider transactions

EDGAR

Sage Therapeutics, Inc.

Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, read from each filing’s XML. Codes and their wording are the SEC’s own.

A Form 4 is due within two business days of the transaction, so the most recent trades may not be filed yet.

Window: transactions dated on or after 2025-11-18.

Open-market purchases (code P)
0 transactions, — shares
Open-market sales (code S)
0 transactions, — shares

Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.

This issuer has insider filings in the store, but no transaction in this window or code group.

Institutional holders (Form 13F)

Quarter ending 2026-09-30: 8,793 filings read, the latest filed 2026-11-17. Prior quarter ending 2026-06-30: 9,164 filings read.

Showing 1–3 of 3

Institutional holders, largest position first, as filed
ManagerShares or principalValue as filedChange from the prior quarterSource
AdvisorShares Investments LLC 89,780 SH0 dollarsUnchanged Prior quarter: 89,780Open filing 0001829126-26-012138 Filed 2026-11-09 Dispute this row
SouthState Bank Corp Partly reported under another manager9 SH0 dollarsUnchanged Prior quarter: 9Open filing 0001193125-26-453154 Filed 2026-11-09 Dispute this row
Ascentis Independent Advisors 5 SH0 dollarsNot in the prior quarter’s filings read Open filing 0001845003-26-000008 Filed 2026-11-03 Dispute this row
Managers in the prior quarter with no filing read for the latest

They may simply not have filed yet: absent from the latest quarter’s filings read is not the same as a position sold.

  • GAMMA Investing LLC 338 SH
  • HUNTINGTON NATIONAL BANK 1 SH
  • Form 13F covers long positions in Section 13(f) securities only: no short positions and no securities outside that list.
  • A manager that has not yet filed for the latest quarter is absent, not at zero; filings are due up to 45 days after quarter end.
  • A change is the difference between two quarter-end snapshots, not a trade.
  • A position reported under another manager may also appear in that manager’s filing; rows are not added together.
  • Holdings the securities list cannot place with this company, or places ambiguously, are not shown.

Trades by members of Congress

Periodic transaction reports filed by U.S. House members that name this company’s stock. Dates and amounts are as filed.

No House member’s trade in this company is placed in the store. A trade not yet filed or not linked to a company is absent, not zero.

5% holders (Schedule 13D and 13G)

Schedules filed in the SEC’s structured format (late 2024 onward) are read here. Earlier schedules are free text and are not read.

5% holders, newest event first, as filed
HolderPercent of classShares heldEvent dateFormSource
Madison Avenue Partners, LP Common Stock, par value $0.0001 per share (the "Common Stock")0009/30/2025 Filed 2025-11-14SCHEDULE 13G/AAmendment 2Open filing 0001013594-25-001411 Dispute this row
Madison Avenue International LP Common Stock, par value $0.0001 per share (the "Common Stock")0009/30/2025 Filed 2025-11-14SCHEDULE 13G/AAmendment 2Open filing 0001013594-25-001411 Dispute this row
EMAI Management, LLC Common Stock, par value $0.0001 per share (the "Common Stock")0009/30/2025 Filed 2025-11-14SCHEDULE 13G/AAmendment 2Open filing 0001013594-25-001411 Dispute this row
Madison Avenue GP, LLC Common Stock, par value $0.0001 per share (the "Common Stock")0009/30/2025 Filed 2025-11-14SCHEDULE 13G/AAmendment 2Open filing 0001013594-25-001411 Dispute this row
Caraway Jackson Investments LLC Common Stock, par value $0.0001 per share (the "Common Stock")0009/30/2025 Filed 2025-11-14SCHEDULE 13G/AAmendment 2Open filing 0001013594-25-001411 Dispute this row
Eli Samaha Common Stock, par value $0.0001 per share (the "Common Stock")0009/30/2025 Filed 2025-11-14SCHEDULE 13G/AAmendment 2Open filing 0001013594-25-001411 Dispute this row
Biogen Inc. Common Stock, par value $0.0001 per share0007/30/2025 Filed 2025-07-30SCHEDULE 13D/AAmendment 2Open filing 0000950157-25-000596 Dispute this row
Biogen MA Inc. Common Stock, par value $0.0001 per share0007/30/2025 Filed 2025-07-30SCHEDULE 13D/AAmendment 2Open filing 0000950157-25-000596 Dispute this row
Biogen Inc. Common Stock, par value $0.0001 per share106,241,47307/21/2025 Filed 2025-07-21SCHEDULE 13D/AAmendment 1Open filing 0000950157-25-000586 Dispute this row
Biogen MA Inc. Common Stock, par value $0.0001 per share106,241,47307/21/2025 Filed 2025-07-21SCHEDULE 13D/AAmendment 1Open filing 0000950157-25-000586 Dispute this row
Madison Avenue Partners LP Common Stock, par value $0.0001 per share (the "Common Stock")9.76,077,06506/30/2025 Filed 2025-08-14SCHEDULE 13G/AAmendment 1Open filing 0001013594-25-001009 Dispute this row
Madison Avenue International LP Common Stock, par value $0.0001 per share (the "Common Stock")9.76,077,06506/30/2025 Filed 2025-08-14SCHEDULE 13G/AAmendment 1Open filing 0001013594-25-001009 Dispute this row
EMAI Management, LLC Common Stock, par value $0.0001 per share (the "Common Stock")9.76,077,06506/30/2025 Filed 2025-08-14SCHEDULE 13G/AAmendment 1Open filing 0001013594-25-001009 Dispute this row
Madison Avenue GP, LLC Common Stock, par value $0.0001 per share (the "Common Stock")9.76,077,06506/30/2025 Filed 2025-08-14SCHEDULE 13G/AAmendment 1Open filing 0001013594-25-001009 Dispute this row
Caraway Jackson Investments LLC Common Stock, par value $0.0001 per share (the "Common Stock")9.76,077,06506/30/2025 Filed 2025-08-14SCHEDULE 13G/AAmendment 1Open filing 0001013594-25-001009 Dispute this row
Eli Samaha Common Stock, par value $0.0001 per share (the "Common Stock")9.76,077,06506/30/2025 Filed 2025-08-14SCHEDULE 13G/AAmendment 1Open filing 0001013594-25-001009 Dispute this row
The Vanguard Group Common Stock5.213,265,80206/30/2025 Filed 2025-07-29SCHEDULE 13G/AAmendment 12Open filing 0000932471-25-001028 Dispute this row

Percent is of the class the filing names, as the holder stated it. Members of a group each report the group’s shares, so rows are not added together.

What was read

2,251,494 filings read, dated 2004-06-14 to 2026-11-17: Forms 3, 3/A, 4, 4/A, 5, 5/A.

Years can be incomplete while the archive is still being read. A year with few filings here is not a statement that few were made.

Filings read, by filing year
Filing yearFilings read
20151
2016204,322
2017202,494
2018202,048
2019193,638
2020144,184
2021224,474
2022158,941
2023199,811
2024209,823
2025235,520
2026260,174

Filings made before the SEC required XML are listed, not extracted.

Back to Sage Therapeutics, Inc.